Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178048 · ClinicalTrials.gov registry record · Phase 4
Paroxetine in the Treatment of Chronic Primary Insomnia
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 66
- Enrollment target
NCT00178048 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 66 participants.
The verdict
NCT00178048, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 66 participants
- Enrollment target
Study Summary
The goal of the study is to examine the role of paroxetine, an antidepressant medication, in the acute and continuation treatment of insomnia. Primary insomnia is a type of insomnia not directly resulting from general medical, chemical, or psychiatric conditions.
Interventions
- DRUG paroxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 1998-09 |
| Est. Completion | 2003-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00178048
The ClinicalTrials.gov registry entry for NCT00178048 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which paroxetine is the first listed.
NCT00178048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00178048 about?
NCT00178048 is a clinical study titled "Paroxetine in the Treatment of Chronic Primary Insomnia". The goal of the study is to examine the role of paroxetine, an antidepressant medication, in the acute and continuation treatment of insomnia. Primary insomnia is a type of insomnia not directly resulting from general medical, chemical, or psychiatric conditions.
What is the current status of trial NCT00178048?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 66 participants. The study started on 1998-09. Estimated completion is 2003-12.
What interventions are being tested in trial NCT00178048?
The interventions under investigation include: paroxetine (DRUG).
Who is sponsoring clinical trial NCT00178048?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.